Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Turkey / NCT06758973
Enrolling by invitation Observational

Validity and Reliability of the Turkish Version of the 4-Item Short Form of the Pain Anxiety Symptom Scale

NCT06758973 · tracked via the Priya Life Science Turkey tracker
Sponsor
Kirsehir Ahi Evran Universitesi
Phase
Observational
Started
2025-01-29
Last updated
2026-04-20

Condition(s) studied

Scale Reliability Validity

Study summary

The primary aim of the study was to determine the reliability and validity of the Turkish version of the 4-Item Short Form of the Pain Anxiety Symptom Scale. The secondary aim of the study was to determine the level of pain-related anxiety in individuals with chronic pain.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: 1. Between the ages of 18-65 2. Having pain 4 or more days a week 3. Having weekly pain intensity of 3 or more according to the Numeric Pain Rating Scale 4. Having chronic pain lasting at least 3 months 5. Being able to read and write and having no cognitive problems 6. Individuals who volunteer to participate in the study will be included. Exclusion Criteria: 1\. Having pain limited to headache only

Primary outcome measure(s)

  • Pain Anxiety Symptom Scale 4-Item Short Form — 20 weeks

Trial sites (1)

FacilityCityRegionStatus
Kirsehir Ahi Evran University Kırşehir Merkez

More Kirsehir Ahi Evran Universitesi trials in Turkey

The 6-minute Pegboard and Ring Test in Overweight and Obese Individuals Recruiting
Biomarkers in Ankylosing Spondylitis Active, not recruiting
Cardiovascular Disease Risk Factors and Healthy Lifestyle Behaviours in Patients with Ankylosing Spondylitis Recruiting
Activities of Daily Living and Upper Extremity Exercise Capacity of Individuals with High Body Mass Index Recruiting
The Investigation of the Effectiveness of Virtual Reality Applications in Postmenopausal Osteoporosis Patients Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06758973 on ClinicalTrials.gov ↗ ← All trials in Turkey